Evidence map›Paper›PMID 34078664›Full record

ArticleJournal of the American Society of Nephrology : JASN2021

REST and Stress Resistance in the Aging Kidney.

Sato Magassa, Liviu Aron, Clément Hoguin, Pierre Isnard, Fabiola Terzi, Christophe Legendre, Bruce A Yankner, Guillaume Canaud

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sato MagassaUniversité de Paris, Paris, France.
Liviu AronDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Clément HoguinUniversité de Paris, Paris, France.
Pierre IsnardUniversité de Paris, Paris, France.
Fabiola TerziUniversité de Paris, Paris, France.
Christophe LegendreUniversité de Paris, Paris, France.
Bruce A YanknerDepartment of Genetics, Harvard Medical School, Boston, Massachusetts.
Guillaume CanaudUniversité de Paris, Paris, France guillaume.canaud@inserm.fr.
Université Paris Cité · FRHarvard University · USInserm · FR

Funding

Targeting REST in Alzheimer's DiseaseR01AG069042 · NIA · HARVARD MEDICAL SCHOOL · PI YANKNER, BRUCE A · 2021 to 2025
$4.5M
European Research Council 679254NIA NIH HHS R01 AG069042
6 · The paper itself

Abstract

backgroundCKD is associated with the loss of functional nephr ons, leading to increased mechanical and metabolic stress in the remaining cells, particularly for cells constituting the filtration barrier, such as podocytes. The failure of podocytes to mount an adequate stress response can lead to further nephron loss and disease progression. However, the mechanisms that regulate this degenerative process in the kidney are unknown.

methodsWe combined

resultsMice with a specific deletion of

conclusionsThese results suggest REST protects the kidney from injury and degeneration during aging, with potentially important therapeutic implications.

Indexed as

Adaptation, PhysiologicalAdultAgedAged, 80 and overAgingAlbuminuriaAnimalsApoptosisCell LineCell SurvivalCytoskeletonGene Expression RegulationHomeostasisHumansMicePhenotypeRE1-Silencing Transcription FactorRepressor ProteinsagingapoptosiscytoskeletonpodocyteREST

Identifiers

PMID34078664
PMCPMC8455262
OpenAlexW3164536463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.